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Background: The objective of this study was to report the use of multi-targeted polymerase chain reaction (PCR) in
the diagnosis of presumed tubercular uveitis. Multi-targeted PCR using three targets specific for Mycobacterium
tuberculosis, i.e., IS6110, MPB64, and protein b, was performed on intraocular fluid samples of 25 subjects. Nine had
presumed tubercular uveitis, six had intraocular inflammation secondary to a nontubercular etiology (disease
controls), and ten had no evidence of intraocular inflammation (normal controls). As described previously, response
to antitubercular therapy was considered as the gold standard.
Results: Multi-targeted PCR was positive in seven out of nine patients with presumed tubercular uveitis and
negative in all normal and disease controls. The sensitivity and specificity were 77.77% and 100%, respectively. For
the diagnosis of presumed tubercular uveitis, multi-targeted PCR had a positive predictive value of 100% and a
negative predictive value of 88.88%.
Conclusion: Multi-targeted PCR can be a valuable tool for diagnosing presumed tubercular uveitis.
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Establishing a definitive diagnosis of presumed tubercu-
lar uveitis is a challenge as the intraocular specimen is
seldom available for histopathological or microbiological
evaluation. A low bacterial count amounting to a nega-
tive acid-fast bacillus smear examination and a delay of
about 4 to 6 weeks in confirming diagnosis by bacterial
culture further limit the utility of these tests in uveitis
patients of presumed tubercular etiology [1,2]. The
newer tests like interferon gamma release assays could
not differentiate latent from active infection. Also, the
nucleic acid amplification techniques (NAAT) like poly-
merase chain reaction (PCR) have limited sensitivity
[3,4]. Hence, the proposed guidelines for diagnosis of
presumed tubercular uveitis are still based on suggestive
clinical history, signs, supportive investigations, such as
positive tuberculin skin test (TST)/QuantiFERON-TB
Gold test or a positive chest X-ray, exclusion of other
known etiologies of uveitis, and a favorable response* Correspondence: eyepgi@sify.com
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in any medium, provided the original work is pto antitubercular therapy (ATT) [1,3-7]. One of the reasons
for poor sensitivity of PCR was the absence of a particular
genome in 20% to 40% isolates of Mycobacterium
tuberculosis (MTB) [8-11]. However, the simultaneous
amplification of IS6110 and MPB64 in patients with
osteoarticular tuberculosis (TB) and IS6110, MPB64, and
protein b in patients with TB meningitis (TBM) resulted in
enhanced sensitivity of 82.5% and 86.63%, respectively
[12,13]. We standardized and validated a multi-targeted
PCR using three target genes simultaneously, namely
IS6110, MPB64, and protein b, for establishing a diagnosis
of TB and hence conducted the study to assess the role of
this novel multi-targeted PCR in the diagnosis of presumed
tubercular uveitis.
Methods
From a total of 25 patients, 18 vitreous fluid samples, 6
aqueous fluid samples, and 1 iris biopsy were taken for the
study. These 25 patients were divided into three groups:
1. Group 1 included nine patients with presumed
tubercular uveitis based on clinical signs and
corroborative evidence [1]. The diagnosis of TB
was presumed when the patient hadan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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anterior chamber, with or without
granulomatous keratic precipitates or iris
nodules, iris granuloma, vitreous cells, snowballs,
snowbanking, retinal vasculitis with/without
perivascular choroiditis scars with/without
vitreous hemorrhage or tractional retinal
detachment, serpiginous-like choroiditis,
choroidal granuloma, or neuroretinitis.
(b)A positive TST according to the CDC
recommendations [29] (TST, 10 mm induration
or more at 48 to 72 h) or QuantiFERON-TB
Gold test, or a positive chest X-ray.
(c) All known causes of infectious uveitis or known
noninfectious uveitis syndromes ruled out.
Patients already receiving ATT prior to initiating
our study were excluded.2. Group 2 included six patients with evidence of
intraocular inflammation. These served as positive
disease controls and had the following inclusion
criteria:(a) Evidence of active inflammation in the anterior
and/or posterior segment.
(b) A documented negative TST (less than 10 mm of
induration) at 48 to 72 h and/or negative
QuantiFERON-TB Gold test, and a negative
chest X-ray for TB.
(c) No evidence of extraocular manifestation of TB.
(d) Never received ATT.3. Group 3 included ten patients without any evidence of
inflammation in the eye who underwent intraocular
surgery for noninflammatory ocular conditions such
as cataract surgery or vitreous surgery for retinal
detachment, macular hole, etc. This group served as
the normal controls. No additional tests were done
for this group of patients.
Depending upon the severity of intraocular inflamma-
tion in the anterior or posterior segment in groups 1 and
2, aqueous or vitreous fluid samples were obtained for the
PCR analysis. In group 3, aqueous or vitreous samples
were collected depending upon the intraocular surgery
being performed (cataract or vitreous surgery). Hence, of
nine patients in group 1, aqueous sample was collected
from one patient (chronic anterior uveitis with compli-
cated cataract), vitreous from seven (serpiginous-like chor-
oiditis with scleritis (one), retinal vasculitis (three),
choroidal granuloma (one), panuveitis (one), intermediate
uveitis (one)), and iris biopsy from one patient (iris granu-
loma). In group 2, all six patients underwent vitreous fluid
sample analysis. In group 3, aqueous and vitreous fluidsamples were obtained from five patients each. All samples
were subjected to MPCR.
Group 1 patients underwent baseline uveitis investiga-
tions that included TST and/or QFT-TB Gold test, chest
X-ray, hemogram, erythrocyte sedimentation rate, and
Treponema pallidum hemagglutination (TPHA) test.
When required, as after a negative response to ATT,
patient no. 8 (recalcitrant panuveitis with rhegmatogen-
ous retinal detachment) underwent pars plana vitrec-
tomy with internal tamponade. No additional laboratory
tests were done. Patient no. 9, after a failed response to
ATT and corticosteroids, underwent brain MRI on cli-
nically suspecting primary intraocular lymphoma
(PIOL), followed by a chorioretinal biopsy for cytological
examination that confirmed the diagnosis of PIOL. In
group 2 patients, the investigations were ordered as follows:
TST, chest X-ray, and TPHA test in intermediate uveitis
(one), which were negative; smear and culture examination
of the vitreous sample in postoperative (one) and posttrau-
matic (one) endophthalmitis; smear and culture evaluation
of vitreous, blood, and urine samples in presumed en-
dogenous endophthalmitis (one); and serology for Toxo-
plasma antibodies in toxoplasmic retinochoroiditis (one).
The remaining patient with phacoantigenic uveitis did
not require investigations specific to uveitis.
Patients in group 3 were included only to serve as nor-
mal (disease-free) controls. These patients underwent a
detailed ocular examination as a routine protocol prior
to surgery. Since there was no evidence of any intraocu-
lar inflammation, uveitis-related investigations were not
considered in these patients. All patients in group 1 were
reviewed by a consultant internist. None in groups 2 and
3 required his consultation.
Prior to enrolment, all patients had undergone a detailed
ocular examination including best-corrected visual acuity,
intraocular pressure, and slit lamp biomicroscopy. Ancillary
tests like fundus photography, fundus fluorescein angiog-
raphy, spectral domain optical coherence tomography, and
ultrasound B scan were performed as and when required.
Systemic evaluation was done by a consultant internist
(AS) with special interest in systemic inflammatory dis-
eases. This study has been approved by the Institute Ethics
Committee.
Collection of samples
An informed consent was taken from all the study partici-
pants. The vitreous humor, aqueous fluid, and/or iris biopsy
were collected from the eye with active uveitis (groups 1
and 2) under strict aseptic precautions and transferred to
the laboratory immediately.
Extraction of DNA and running samples for PCR
DNA was extracted from the samples using DNeasy Tis-
sue Kit (QIAGEN, Hilden, Germany) according to the
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mens were stored at −20°C until used.
Multi-targeted PCR
Multi-targeted PCR was carried out as described previ-
ously [12]. To check the internal reproducibility of the
test, it was repeated three times and put up by two
people independently. In each independent muti-
targeted PCR assay, test results were compared with the
results for one positive and one negative control. The posi-
tive control included the DNA of H37Rv, and the negative
control included PCR-grade water. Identification of MTB
was done using a specific pair of primers designed to amp-
lify IS6110, protein antigen b, andMPB64 in the MTB com-
plex, and the expected band size was 123 bp for IS6110,
419 bp for protein b, and 240 bp forMPB64. The sequences
of primers used for protein b PCR were Pab f and Pab r: 5-
ACC ACC GAG CGG TTC GCC TGA-3 and 5-GAT
CTG CGG GTC GTC CCA GGT-3, respectively. Primers
used for IS6110 were IS1: CCTGCGAGCGTAGGCGT-30
and IS2: 5-CTCGTCCAGCG CCGCTTCGG-3. Primers
used for MPB64 were MPB1: 5-TCC GCT GCC AGT
CGT CTT CC-30 and MPB2: 50-GTC CTC GCG AGT
CTA GGC CA-3. The following components were added
to the Eppendorf tube (for a 50-μl reaction): PCR buffer
(10X), dNTPs (Mix,10 mM), primer IS1 (10 pm/μl), IS2
(10 pm/μl), P1 (10 pm/μl), P2 (10 pm/μl), MPB1 (10 pm/
μl), MPB2 (10 pm/μl), Taq polymerase (5 U/μl), DNA tem-
plate, and water. DNA amplification was performed for
40 cycles following an initial denaturation step at 94°C for
5 min in a thermocycler using the following program: de-
naturation at 94°C for 1 min, annealing at 65°C for 1.5 min,
extension at 72°C for 1.5 min, and final extension at 72°C
for 10 min.
The amplified product was stored at 4°C until detec-
tion on 1.5% agarose gel stained with ethidium bromide.
The stained gel was examined under UV light to look
for bands 123 bp for IS6110, 419 bp for protein b, and
240 bp for MPB64 using a molecular weight marker of
100-bp ladder. The samples showing the presence of
these bands under ultraviolet transillumination were
considered positive.
Specificity and sensitivity of the MPCR assay
In agreement with Eisenach et al. [30], muti-targeted
PCR was highly specific for MTB in a preliminary study.
No amplification product was produced with other
Mycobacterium species, such as M. avium, M. fortuitum,
or M. kansasii (data not shown). Sensitivity was esti-
mated by serial dilutions of MTB DNA. The MPCR
detected 10 fg, which is equivalent to two mycobacterial
genomes.Multi-targeted PCR quality control
To avoid contamination during DNA extraction and
amplification, strict precautions were taken, including
separate areas for DNA extraction, reagent preparation,
amplification and product detection, and regular meticu-
lous cleaning of surfaces with 10% hypochlorite. In
addition, all the reagents were aliquoted upon arrival in
the laboratory. Positive and negative controls were
included with each set of reaction. The positive control
was DNA extracted from H37RV, whereas the negative
control was PCR-grade water. To demonstrate the pres-
ence of inhibitors in multi-targeted PCR, all negative
samples were spiked with positive control DNA, and no
inhibitors were detected on spiked samples as all were
positive with spiked DNA.
Statistical methods
The sensitivity, specificity, positive predictive value, and
negative predictive value were calculated using standard
formulae as follows (positive test: a = disease, b = no di-
sease; negative test: c = disease, d = no disease):
 Sensitivity = a / (a + c).
 Specificity = d / (b + d).
 Positive predictive value = a / (a + b).
 Negative predictive value = d / (c + d).
Results
Group 1 comprised of nine patients with six males and
three females. The mean age was 42.5 ± 9.8 years (range
30 to 50 years). Group 2 (six positive controls) had five
males and one female. The mean age was 42 ± 20.8 years
(range 4 to 60 years). Group 3 (ten negative controls)
had five males and five females. The mean age was 47.9
± 19.8 years (range 5 to 70 years).
The clinical diagnosis in group 1 included vasculitis
with or without vitreous hemorrhage/tractional retinal
detachment (three), panuveitis (one), serpiginous-like
choroiditis (one), choroidal granuloma (one), intermedi-
ate uveitis (one), chronic anterior uveitis (one), and iris
granuloma (one). Table 1 shows the details of clinical
signs in groups 1 and 2.
Of nine patients with presumed tubercular uveitis
(group 1), seven (77.77%) were positive by multi-
targeted PCR (Figure 1). Of these seven multi-targeted
PCR-positive cases, all three bands (IS6110, protein b,
and MPB64) were present in two cases, and two bands
(MPB64 and IS6110) were present in two cases, and a
single band each for MPB64 and IS6110 was present in
two cases and one case, respectively (Table 2). Sensitivity
of IS6110 and MPB64 was 55.55% and 66.66%, respec-
tively. By using all the three primers, sensitivity of multi-
targeted PCR was higher (77.77%). Since multi-targeted
PCR was negative in groups 2 and 3 subjects, the
Table 1 Clinical ocular details of patients in groups 1 and 2 who underwent multi-targeted PCR analysis
Patient
no.
Group 1 Group 2
Diagnosis Clinical signs Diagnosis Clinical signs
1 RE serpiginous-
like choroiditis
Serpiginous-like choroiditis RE phacoantigenic
uveitis










RE vitreous cells ++, rhegmatogenous RD; LE vitreous hemorrhage BE intermediate
uveitis




Iris granuloma, AC cells ++, flare + RE endogenous
endophthalmitis
AC cells ++, flare +, vitreous
cells +++, exudates ++
5 LE retinal
vasculitis






Cells ++, flare ++, complicated cataract, seclusiopupillae LE posttraumatic
endophthalmitis
Hypopyon, flare +++,
cataract, vitreous exudates ++
7 RE intermediate
uveitis
Vitreous cells +++, snowballs - -
8 BE panuveitis RE AC cells ++, flare ++, seclusiopupillae, rhegmatogenous RD; LE




Vitreous cells +++, vasculitis - -
RE, right eye; LE, left eye; BE, both eyes; AC, anterior chamber; RD, retinal detachment; CME, cystoid macular edema.
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PCR, MPB64, IS6110, and protein b PCR were 77.77%,
66.66%, 55.55%, and 22.22%, respectively (Table 3).
Multi-targeted PCR had a positive predictive value of
100% and a negative predictive value of 88.88%.
The median follow-up of seven patients with a positive
multi-targeted PCR in group 1 was 18 months (range 1.5
to 28 months). All patients were started on ATT with
corticosteroids (oral/topical). Six of these patients were
quiescent at the final visit. One developed recurrence of
anterior segment inflammation (cell 2+, flare 2+) during
follow-up. Of the other two cases that were negative byFigure 1 Results of multi-targeted PCR. Lane 1 - 100-bp MM; lane
2 - positive control showing all three bands, i.e., 123-bp IS6110, 240-
bp MPB64, and 419-bp protein b; lane 3-negative control; lane 4 -
positive clinical sample by all three bands; lane 5 and lane 7 -
clinical sample positive by IS6110 and MPB64 bands; lane 6 -
negative clinical sample; lane 8 - clinical sample only IS6110 positive.multi-targeted PCR, one (patient no. 8) presented with
right eye retinal vasculitis with rhegmatogenous retinal
detachment and left eye intermediate uveitis. The TST
was positive. The patient underwent pars plana vitrec-
tomy with silicon oil tamponade in the right eye and
received ATT with oral corticosteroids. The left eye
showed persistent inflammation despite treatment at
19 months of follow-up. The other case (patient no. 9)
presented with diffuse retinal vasculitis in the right eye
and had a positive TST but did not respond to oral cor-
ticosteroids and ATT. The patient developed discrete
hypopigmented lesions in the fundus that were below
the retinal pigment epithelium as revealed by spectral
domain optical coherence tomography. Following a
negative vitreous biopsy report and other relevant inves-
tigations, the patient underwent a repeat vitreous sur-
gery for obtaining retinal and subretinal biopsy that
revealed an intraocular B-cell lymphoma.
Discussion
The clinical diagnosis of presumed tubercular uveitis is
challenging due to protean manifestations, especially in
an endemic country and BCG-vaccinated population.
The chronic, recurrent nature of the disease demands an
early and accurate diagnosis since a highly effective ATT
is available for treating these patients. The NAAT have
emerged as important tools for a rapid and an accurate
diagnosis of TB. A meta-analysis of NAAT used in the
diagnosis of TB concluded that commercial tests yielded
results with high specificity but low sensitivity especially
in smear-negative cases, while heterogeneity and low
Table 2 Detailed genome results of positive MPCR in
seven of nine cases of presumed tubercular uveitis
Specific genome results (group 1) Number of samples
IS6110 positive alone 1
MPB64 positive alone 2
Both MPB64 and IS6110 positive 2
All three positive (MPB64, IS6110, and protein b) 2
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tests [14].
For the diagnosis of MTB, a large number of different
sequences of the Mycobacterium genome have been tar-
geted [15-17]. Most of the NAAT-based diagnostic
methods have used a single target (e.g., IS6110) for the
amplification and detection of tuberculosis [18]. Since
IS6110 is absent in 10% to 40% of MTB isolates espe-
cially in geographically endemic areas like India, the like-
lihood of false-negative tests is increased [10,11,18]. A
low sensitivity (37.7%) has been reported with PCR in
ocular samples from presumed tubercular uveitis
patients [6]. An alternative approach is to use multi-
targeted PCR, in which several target genes are amplified
simultaneously. This improves the sensitivity, specificity,
and rapidity of diagnosis, as seen in pulmonary [19,20]
and extrapulmonary TB [12,13,21]. In the present study,
though small, the sensitivity of multi-targeted PCR was
77.7%. We have developed and validated multi-targeted
PCR (MPCR) using three different targets, i.e., IS6110,
MPB64, and protein antigen b (Pab). To check the in-
ternal reproducibility of the test, it was repeated three
times and put up by two people independently.
In the present study, we evaluated MPCR using three dif-
ferent targets, i.e., IS6110, MPB64, and Pab specific for
MTB. IS6110 was chosen because of multiple copy num-
bers of IS6110 (6 to 24) in the MTB genome, making it an
attractive target for PCR amplification [5]. MBP64 and pro-
tein b primers had shown good sensitivity for detection ofTable 3 Sensitivity and specificity of MPCR in presumed tube
Test Test
results
Group 1 Groups 2 and 3
(n = 9) (n = 16)
MPCR Positive 7 -
Negative 2 16
MPB64 Positive 6 -
Negative 3 16
IS6110 Positive 5 -
Negative 4 16
Protein b Positive 2 -
Negative 7 16
PPV, positive predictive value; NPV, negative predictive value.MTB in our previous experience for the diagnosis of TBM
patients [12].
For the diagnosis of tubercular uveitis, most of the
previous studies had used only IS6110. The sensitivity of
PCR is reported between 37% and 58.82% [6,7]. In the
present study, sensitivity of IS6110 was 55.55%, which is
comparable to that of previously reported studies [6,7].
The sensitivity of MPB64 was 66.66%, and the specificity
was 100%. An important finding was the presence of
two cases, which were only MPB64 positive but IS6110
negative. In the absence of MPB64 primers, these cases
would have tested negative for MTB. Similarly, one case
that was only IS6110 positive would have tested MTB
negative by using only MPB64 primers. MPB64 as a tar-
get for diagnosis of tubercular uveitis has been evaluated
in 23 patients suspected of Eales' disease and 27 control
group subjects by Madhavan et al. and had shown a sen-
sitivity of 47.8% and a specificity of 88.8% [22]. The
authors mentioned that MPB64 is 10,000 times more
sensitive than IS6110 for the diagnosis of tubercular
uveitis.
Protein b PCR was positive in two out of nine patients
in group 1. Protein b is a 38-kDa protein which is spe-
cific for MTB complex. This genome has not been eva-
luated for diagnosis of tubercular uveitis previously. It
did not enhance the sensitivity of MPCR in the present
study but had a good specificity for diagnosis of TBM in
a previous study [23] and needs to be evaluated in a lar-
ger number of patients in future prospective studies for
diagnosis of tubercular uveitis.
Multiple gene amplification studies for the diagnosis
of tubercular uveitis have not been reported, although a
few studies have evaluated multiple targets as separate
uniplex PCRs in other extrapulmonary conditions. These
have not been studied as multi-targeted PCR and had
reported increase in sensitivity by using two targets to-
gether [24]. This multi-targeted PCR was validated in
culture-positive sputum samples in another laboratory
(unpublished data). In our previous report of patientsrcular uveitis patients and disease and normal controls
Sensitivity Specificity PPV NPV
(%) (%) (%) (%)
77.77 100 100 88.88
66.66 100 100 84.21
55.55 100 100 80.00
22.22 100 100 69.56
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the sensitivity of multi-targeted PCR was 94.4% in con-
firmed cases of TBM and 84.4% in suspected cases of
TBM, and the specificity was 100% [12]. In the present
study, sensitivity and specificity of multi-targeted PCR
for diagnosis of presumed tubercular uveitis were 77.7%
and 100%, respectively. Two of group 1 patients had a
negative MPCR. A possible reason for a negative result
by multi-targeted PCR in patient 8 could be due to a
low number of bacteria or poor lysis of bacteria in the
ocular fluids. The tough cell wall of bacteria also can
make the isolation of DNA difficult [25]. It could also be
affected by the presence of inhibitors in the samples
[26]. However, since patient no. 8 showed a poor re-
sponse to ATT and oral corticosteroids, a nontubercular
etiology or drug resistance cannot be ruled out. Patient
no. 9 with a negative MPCR had primary intraocular
B-cell lymphoma that was diagnosed from a subretinal
biopsy following a poor response to ATT and oral corti-
costeroids. If we exclude the case of B-cell lymphoma
(patient no. 9) from group 1, the sensitivity of multi-
targeted PCR increases to 90%. To the best of our know-
ledge, this is the first attempt to describe the use of
novel multi-targeted PCR for diagnosing presumed
tubercular uveitis.
Presence of TB DNA in the ocular fluid suggests the
presence of Mycobacterium infection within the eye but
does not differentiate the clinical picture from an im-
mune response to mycobacterial antigens being loaded
from the retinal pigment epithelium (RPE) cells, a pos-
sible sanctuary for MTB, or from somewhere else in the
body. Demonstration of several acid-fast bacteria loca-
lized within the necrotic RPE cells in an earlier report by
Rao et al. supports the possibility of tubercular uveitis as
an immune response to these sequestered bacteria
within the RPE cells [27]. DNA-based PCR cannot dif-
ferentiate between active and dormant infection. In a la-
tent infection of the eye, a healthy and disease control
group patient may also have a positive multi-targeted
PCR, but this needs to be studied in a larger number of
patients. The advantage of this study is that due to the
inherent paucibacilliary nature of the disease, resulting
in negligible culture positivity, response to ATT and
multi-targeted PCR positivity may be surrogate markers
for uveitis of tubercular origin. However, even though a
highly effective ATT treatment is available, this treat-
ment is not free of adverse effects and some degree of
certainty in the diagnosis of tuberculous uveitis in the
form of clinical signs and corroborative laboratory evi-
dence is needed before putting patients on treatment.
We have earlier reported the use of quantitative PCR
that allowed a fast detection and quantification of the
mycobacterial load in the tested specimens of presumed
tubercular uveitis [28]. However, our study has certainlimitations, a small number of patients being the major
limitation. The gold standard used in our study for diag-
nosing tubercular uveitis is a subject of major concern
and controversy. In the absence of mycobacterial culture
as the gold standard for diagnosing TB infection, the
next best alternative for labeling these patients as having
presumed tubercular uveitis is a favorable response to
ATT in addition to the corroborative laboratory evi-
dence, as used by many studies over the years. Also, our
control group 3 has potential flaws. These patients were
enrolled for cataract or vitreoretinal surgery. In the ab-
sence of any evidence of uveitis (active or inactive), these
patients were presumed to be normal, and investigations
related to uveitis work-up were not considered necessary
in them. The follow-up is limited in our patients. Due to
weaknesses in the study design, we are not able to arrive
to statistically significant conclusions and are just sho-
wing preliminary results that would need further study.
Early diagnosis and prompt treatment of presumed
tubercular uveitis is required for better patient outcome.
Novel multi-targeted PCR using three primers has
shown a high sensitivity and specificity for diagnosing
presumed tubercular uveitis.Conclusions
In resource-limited countries that are endemic for tuber-
culosis, multi-targeted PCR has a high potential to be
used as a diagnostic modality. However, more studies
with a large sample size are required to corroborate its
utility in a rapid and accurate diagnosis of presumed tu-
bercular uveitis.
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